The HIV 1 and 2 antibody rapid test is a point-of-care screening test that detects antibodies to HIV‑1 and HIV‑2 in blood or oral fluid, giving results in about 15–20 minutes. It’s useful for quick screening with high sensitivity but has a window period (often up to three months) before antibodies appear. Reactive results need laboratory confirmatory testing and follow-up care.

An HIV 1 and 2 test kit detects infection by identifying antibodies (and in some kits the p24 antigen) specific to HIV‑1 and HIV‑2. Available as rapid point‑of‑care tests (finger‑prick or oral), lab ELISA, or nucleic acid tests, it screens for infection; reactive results need confirmatory testing. Accuracy depends on timing—there’s a window period—so repeat testing and clinical follow‑up are recommended.

Yes. Most modern HIV screening tests (including fourth‑generation antigen/antibody assays) are designed to detect both HIV‑1 and HIV‑2. Nucleic acid tests usually detect HIV‑1 RNA, though specialized NATs can identify HIV‑2. Some rapid tests vary, so positive results are followed by confirmatory/differentiation assays that determine whether infection is HIV‑1 or HIV‑2 and guide treatment.

Costs vary widely: many public health or sexual‑health services offer HIV‑1/2 ELISA testing free or subsidized. In private settings, prices differ by country—roughly ₹200–800 in India and about $20–150 (sometimes up to $200) in the US; private‑lab packages or confirmatory panels can raise overall billing. Always check local clinics, insurance coverage, or government programs for exact costs.

HIV‑1 and HIV‑2 test negative means laboratory tests found no evidence of HIV infection at the time of testing — no detectable antibodies, antigen (p24), or viral RNA depending on the assay. A negative result is reliable after the window period, but recent exposure can cause false negatives; follow-up testing per guidelines (often at 4–6 weeks and again at 3 months) is recommended if exposure was recent.

How to use an HIV-1/2 rapid test: Read kit instructions, wash hands, collect the sample as directed (finger-prick or oral swab), add buffer, and wait the specified time (usually 15–20 minutes). One control line only = negative; control plus test line = reactive (preliminary positive); no control line = invalid. Any reactive or invalid result needs confirmatory lab testing and clinical follow-up; retest after the 4–12 week window period.